← Back to headlines
Obesity Drugmaker Kailera Plans IPO
Kailera, a pharmaceutical company specializing in obesity drugs, is reportedly planning an Initial Public Offering (IPO).
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
